Aurora Cannabis (ACB) EBT Growth (1y) (2018 - 2026)
Aurora Cannabis (ACB) EBT Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 64.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,980.23% |
| Dec 31, 2025 | -105.70% |
| Sep 30, 2025 | -12,684.78% |
| Jun 30, 2025 | -428.88% |
| Mar 31, 2025 | -105.74% |
| Dec 31, 2024 | 257.82% |
| Sep 30, 2024 | -35.87% |
| Jun 30, 2024 | 100.09% |
| Dec 31, 2023 | 97.67% |
| Sep 30, 2023 | 100.08% |
| Jun 30, 2023 | -881.40% |
| Dec 31, 2022 | -801.62% |
| Sep 30, 2022 | -5,253.55% |
| Jun 30, 2022 | -362.82% |
| Mar 31, 2022 | -887.87% |
| Dec 31, 2021 | 74.12% |
| Sep 30, 2021 | 89.18% |
| Jun 30, 2021 | 96.98% |
| Mar 31, 2021 | -17.58% |
| Dec 31, 2020 | 76.85% |